But with two of the systems, the error rates for the darkest-skinned women in the data set — those assigned a score of VI — were worse still: 46.5percentand46.8percentcent.
The number of Somali-born women in each data set varies considerably from just 72 (0.3%) in the Belgium-Brussels data set to 3450 (0.8%) in the Swedish data set.
There were 11,181 women with a diagnosis of depression and 14,102 women with a diagnosis of an anxiety disorder who did not use psychotropic medicines during pregnancy representing 57% and 62% of women in our data set with these diagnoses, respectively.
Our primary outcome was nuclear cataract, defined as a nuclear sclerosis severity score of 4 or greater in the worst eye and/or a history of cataract extraction in either eye; all women in the data set had information that used this definition (N = 1,811).
We excluded women from each cohort data set (usually below 3% of all women) with missing data on hysterectomy.
All analyses were repeated only in the breast cancer-free women (27K data set) but not in the DES-unexposed women from the 450K data set because this would have produced a highly underpowered analysis due to the small sample size.
These interviews were organized around the themes of how these women navigated their pregnancies, experienced their childbirths, and coped with the early months of feeding their babies, but these women were asked the same set of questions about infant feeding as the women in the first data set.
In addition to OS and BCSS, Adjuvant! also provided predictions of EFS for women in the Churchill data set.
This is expected, as chemotherapy was targeted at women in the Churchill data set with the poorest prognoses (i.e., those most likely to benefit).
The data presented in Tables 1, 2, 3 of this paper showed that although both Adjuvant! predictions and observed outcomes generally displayed the expected trends across demographic, pathologic, and treatment subgroups, Adjuvant!'s estimates of outcome were almost consistently (and in some cases significantly) greater than the observed outcomes of the women in the Churchill Hospital data set.
